Success Metrics

Clinical Success Rate

100.0%

Based on 7 completed trials

Completion Rate

100%(7/7)

Active Trials

3(30%)

Results Posted

43%(3 trials)

Phase Distribution

Ph phase_3

60%

Ph not_applicable

10%

Ph phase_4

30%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution10 total trials

Phase 3Large-scale testing

6(60.0%)

Phase 4Post-market surveillance

3(30.0%)

N/ANon-phased studies

1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(7)

Detailed Status

Completed7

Active, not recruiting2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 36 (60.0%)

Phase 43 (30.0%)

N/A1 (10.0%)

Trials by Status

recruiting110%

completed770%

active_not_recruiting220%

Recent Activity

3 active trials

Showing 5 of 10

active_not_recruitingphase_3

Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)

NCT04978272

recruitingphase_3

Safety of Antimalarials in the FIRst trimEster

NCT06962319

completedphase_3

Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda

NCT04336189

active_not_recruitingphase_3

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

NCT05426434

completedphase_4

Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania

NCT04245033

View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials

NCT04978272Phase 3

Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)

Active Not Recruiting

NCT06962319Phase 3

Safety of Antimalarials in the FIRst trimEster

Recruiting

NCT04336189Phase 3

Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda

Completed

NCT05426434Phase 3

Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

Active Not Recruiting

NCT04245033Phase 4

Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania

Completed

NCT03178643Phase 4

Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE)

Completed

NCT03576313Phase 3

Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination

Completed

NCT05060198Not Applicable

Therapeutic Efficacy Study of AL and DP in Western Kenya

Completed

NCT00948896Phase 3

Chemopreventive Therapy for Malaria in Ugandan Children

Completed

NCT02009215Phase 4

School-Based Treatment With ACT to Reduce Transmission

Completed

All 10 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 10